Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Novo Integrated Sciences Inc NVOS

Novo Integrated Sciences, Inc. owns Canadian and United States subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative... see more

Recent & Breaking News (GREY:NVOS)

Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results

Business Wire December 18, 2024

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

Business Wire July 19, 2024

Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

Business Wire July 18, 2024

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

Business Wire June 13, 2024

Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

Business Wire June 6, 2024

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products

Business Wire June 5, 2024

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

Business Wire June 3, 2024

Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program

Business Wire May 31, 2024

Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

Business Wire May 30, 2024

Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results

Business Wire April 15, 2024

Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement

Business Wire April 11, 2024

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

Business Wire March 26, 2024

Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.

Business Wire February 21, 2024

Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note

Business Wire February 20, 2024

Novo Integrated Sciences Appoints New President

Business Wire February 16, 2024

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

Business Wire January 22, 2024

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

Business Wire December 19, 2023

Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results

Business Wire December 14, 2023

Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India

Business Wire December 5, 2023

Novo Integrated Sciences' Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval

Business Wire December 4, 2023